Showing results (81-90 of 108) with videos related to
Sort By:
Pageof 11
Journal of Clinical Microbiology|August 7, 2004
Comparison of results of fluconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance programM A Pfaller, K C Hazen, S A Messer, et al.Journal of Clinical Microbiology|September 12, 2008
Validation of 24-hour fluconazole MIC readings versus the CLSI 48-hour broth microdilution reference method: results from a global Candida antifungal surveillance programM A Pfaller, L B Boyken, R J Hollis, et al.Journal of Clinical Microbiology|February 4, 2011
Validation of 24-hour posaconazole and voriconazole MIC readings versus the CLSI 48-hour broth microdilution reference method: application of epidemiological cutoff values to results from a global Candida antifungal surveillance programM A Pfaller, L B Boyken, R J Hollis, et al.Journal of Clinical Microbiology|September 17, 1998
Fluconazole susceptibility testing of Cryptococcus neoformans: comparison of two broth microdilution methods and clinical correlates among isolates from Ugandan AIDS patientsC J Jessup, M A Pfaller, S A Messer, et al.Antimicrobial Agents and Chemotherapy|September 3, 1999
In vitro activities of BMS-207147 against over 600 contemporary clinical bloodstream isolates of Candida species from the SENTRY Antimicrobial Surveillance Program in North America and Latin AmericaD J Diekema, M A Pfaller, S A Messer, et al.Infection Control and Hospital Epidemiology|December 1, 1996
Nasal and cutaneous carriage of Staphylococcus aureus in hemodialysis patients: the effect of nasal mupirocinJ R Boelaert, H W Van Landuyt, B Z Gordts, et al.Journal of Clinical Microbiology|January 14, 2011
Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing with the 24-hour CLSI BMD method for testing susceptibility of Candida species to fluconazole, posaconazole, and voriconazole by use of epidemiological cutoff valuesM A Pfaller, A Espinel-Ingroff, L Boyken, et al.Journal of Clinical Microbiology|January 9, 2003
Characterization of heteroresistance to fluconazole among clinical isolates of Cryptococcus neoformansT Yamazumi, M A Pfaller, S A Messer, et al.Journal of Clinical Microbiology|March 30, 2002
Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms studyD J Diekema, S A Messer, A B Brueggemann, et al.Journal of Clinical Microbiology|August 30, 2001
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance programM A Pfaller, D J Diekema, R N Jones, et al.Pageof 11